Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma

被引：0
|
作者：
Ciesielski, Michael J.
Ahluwalia, Manmeet Singh
Reardon, David A.
Abad, Ajay P.
Curry, William T.
Wong, Eric T.
Peereboom, David M.
Figel, Sheila A.
Hutson, Alan
Groman, Adrienne
Withers, Henry G.
Liu, Song
Belal, Ahmed
Qiu, Jing-Xin
Mogensen, Kathleen
Schilero, Cathy
Casucci, Danielle M.
Mechtler, Laszlo
Fenstermaker, Robert Alan
机构：
[1] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
[2] Taussig Canc Inst, Neurol Inst, Rose Ella Burkhardt Brain Tumor & Neuro Oncol Ctr, Cleveland, OH USA
[3] Cleveland Clin, Cleveland, OH USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Massachusetts Gen Hosp, Boston, MA USA
[7] Beth Israel Deaconess Med Ctr, Boston, MA USA
[8] MimiVax, Buffalo, NY USA
[9] Dent Neurol Inst, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2037
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
    Roth, Patrick
    Gorlia, Thierry
    Reijneveld, Jaap C.
    de Vos, Filip
    Idbaih, Ahmed
    Frenel, Jean-Sebastien
    Le Rhun, Emilie
    Sepulveda, Juan Manuel
    Perry, James
    Masucci, G. Laura
    Freres, Pierre
    Hirte, Hal
    Seidel, Clemens
    Walenkamp, Annemiek
    Lukacova, Slavka
    Meijnders, Paul
    Blais, Andre
    Ducray, Francois
    Verschaeve, Vincent
    Nicholas, Garth
    Balana, Carmen
    Bota, Daniela A.
    Preusser, Matthias
    Nuyens, Sarah
    Dhermain, Frederic
    van den Bent, Martin
    O'Callaghan, Chris J.
    Vanlancker, Maureen
    Mason, Warren
    Weller, Michael
    NEURO-ONCOLOGY, 2024, 26 (09) : 1670 - 1682
  • [42] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly diagnosed glioblastoma multiforme: Final results
    Peereboom, D. M.
    Brewer, C. J.
    Sub, J. H.
    Stevens, G. H.
    Barnett, G. H.
    Toms, S. A.
    Elson, P.
    Vogelbaum, M. A.
    Weil, R. J.
    NEURO-ONCOLOGY, 2006, 8 (04) : 448 - 448
  • [43] A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma
    Furman, Wayne L.
    McGregor, Lisa M.
    McCarville, M. Beth
    Onciu, Mihaela
    Davidoff, Andrew M.
    Kovach, Sandy
    Hawkins, Dana
    McPherson, Valerie
    Houghton, Peter J.
    Billups, Catherine A.
    Wu, Jianrong
    Stewart, Clinton F.
    Santana, Victor M.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1660 - 1670
  • [44] A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma
    Wayne L. Furman
    Lisa M. McGregor
    M. Beth McCarville
    Mihaela Onciu
    Andrew M. Davidoff
    Sandy Kovach
    Dana Hawkins
    Valerie McPherson
    Peter J. Houghton
    Catherine A. Billups
    Jianrong Wu
    Clinton F. Stewart
    Victor M. Santana
    Investigational New Drugs, 2012, 30 : 1660 - 1670
  • [45] Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
    Colombo, N.
    McMeekin, D. S.
    Schwartz, P. E.
    Sessa, C.
    Gehrig, P. A.
    Holloway, R.
    Braly, P.
    Matei, D.
    Morosky, A.
    Dodion, P. F.
    Einstein, M. H.
    Haluska, F.
    BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1021 - 1026
  • [46] Single-arm Phase II cancer survival trial designs
    Wu, Jianrong
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2016, 26 (04) : 644 - 656
  • [47] Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
    N Colombo
    D S McMeekin
    P E Schwartz
    C Sessa
    P A Gehrig
    R Holloway
    P Braly
    D Matei
    A Morosky
    P F Dodion
    M H Einstein
    F Haluska
    British Journal of Cancer, 2013, 108 : 1021 - 1026
  • [48] Optimized Rabbit Antithymocyte Globulin Protocol Plus Sequential Cyclosporine and Levamisole Regimen for Newly Diagnosed Severe Aplastic Anemia: A Single-Arm, SingleCentre, Prospective, Phase 2 Trial
    Ge, Meili
    Huo, Jiali
    Ren, Xiang
    Huang, Jinbo
    Wang, Min
    Nie, Neng
    Zhang, Jing
    Jin, Peng
    Mi, Yingchang
    Shao, Yingqi
    Zheng, Yizhou
    BLOOD, 2023, 142
  • [49] PARTICLE BEAM RADIATION THERAPY PLUS TUMOR TREATING FIELDS IN THE TREATMENT OF NEWLY DIAGNOSED WHO GRADE 4 GLIOMAS: AN EARLY RESULT OF PHASE 2 SINGLE-ARM TRIAL
    Qiu, Xianxin
    Gao, Jing
    Yang, Jing
    Hu, Jiyi
    Hu, Weixu
    Huang, Qingting
    Zhang, Haojiong
    Kong, Lin
    Lu, Jiade
    NEURO-ONCOLOGY, 2022, 24 : 52 - 53
  • [50] Imaging biomarkers correlate with efficacy of bevacizumab combined with conventinal therapy in newly diagnosed conventional therapy in newly diagnosed glioblastoma: an open-label. single arm trial
    Li, Li
    Yuan, Shuanghu
    Yu, Jinming
    Liu, Ning
    Hui, Zhang
    Tao, Rongjie
    Zhao, Shuqiang
    Xu, Liang
    Liu, Yuhui
    Gao, Yongsheng
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12345